The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability and durable respones of the PI3Kδ inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell malignancies.
 
Andrew David Zelenetz
Stock and Other Ownership Interests - Adaptive Biotechnologies
Honoraria - Clinical Care Options; NCCN; Oncology Information Group; PER
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Cancer Support Community; Celgene; Dava Oncology; Genentech/Roche; Gilead Sciences; Janssen; Karyopharm Therapeutics; Medscape; MEI Pharma; MorphoSys; Novartis; Pfizer; Pharmacyclics; Prime Education; TRM Oncology; Vaniam Group; Verastem
Research Funding - BeiGene; Genentech/Roche; Gilead Sciences; MEI Pharma
 
Nishitha Reddy
Honoraria - Celgene; MEI Pharma; MorphoSys
Consulting or Advisory Role - Celgene; MEI Pharma; MorphoSys
Speakers' Bureau - Celgene
Research Funding - BMSi; Merck
 
Deepa Jagadeesh
Consulting or Advisory Role - Atara Biotherapeutics; Kyowa Hakko Kirin; Seagen; Verastem
Research Funding - Debiopharm Group (Inst); MEI Pharma (Inst); Regeneron (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
 
Anastasios Stathis
Research Funding - ADC Therapeutics; Bayer; MEI Pharma; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Abbvie; PharmaMar
 
Huda S. Salman
No Relationships to Disclose
 
Jacob D. Soumerai
Consulting or Advisory Role - Abbvie; AstraZeneca; Verastem
Research Funding - BeiGene; BostonGene; Genentech/Roche; TG Therapeutics
 
Vaishalee Padgaonkar Kenkre
No Relationships to Disclose
 
Adam Steven Asch
Research Funding - Astellas Pharma (Inst); Cartesian Therapeutics (Inst); Forty Seven (Inst); Juno Therapeutics (Inst); Macrogenics (Inst); MEI Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Provisional patent submitted (I)
 
Judith Llorin-Sangalang
Employment - MEI Pharma
Research Funding - MEI Pharma
Travel, Accommodations, Expenses - MEI Pharma
 
Joanne Li
Employment - MEI Pharma
Stock and Other Ownership Interests - Amgen; Lilly
 
Igor Gorbatchevsky
Employment - Bayer; Iovance Biotherapeutics; MEI Pharma
 
John M. Pagel
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; Gilead Sciences; Pharmacyclics